Home
Live Updates
FL118, Drug Candidate Discovered at Roswell Park, Granted FDA Orphan Drug Status for Pancreatic Cancer : comparemela.com
FL118, Drug Candidate Discovered at Roswell Park, Granted FDA Orphan Drug Status for Pancreatic Cancer
The U.S. Food and Drug Administration (FDA) has awarded Orphan Drug Designation to Canget BioTekpharma LLC for FL118, a drug candidate developed at Roswell Park
Related Keywords
United States ,
China ,
New York ,
Chinese ,
American ,
Fengzhi Li ,
Roswell Park ,
Roswell Park Comprehensive Cancer Center ,
Drug Administration ,
Canget Biotekpharma ,
American Chemical Society Journal Of Medicinal Chemistry ,
Roswell Park Care Network ,
Department Of Pharmacology ,
National Cancer ,
Orphan Drug Designation ,
Associate Professor ,
American Chemical Society ,
Medicinal Chemistry ,
Novel Derivative ,
Antitumor Agent Found ,
Chinese Tree Bark ,
New York State ,
National Cancer Institute Designated ,
Upstate New ,
comparemela.com © 2020. All Rights Reserved.